Advertisement

Topics

GSK Selects 3rd Target in Immunocore Oncology Alliance

04:34 EDT 5 Jul 2017 | Contract Pharma

Will generate a novel ImmTAC molecule against the selected target which is relevant in multiple cancers

Original Article: GSK Selects 3rd Target in Immunocore Oncology Alliance

NEXT ARTICLE

More From BioPortfolio on "GSK Selects 3rd Target in Immunocore Oncology Alliance"

Advertisement
Quick Search
Advertisement
Advertisement